title: Current status of chemotherapy for urothelial tract tumors.
abstract: The standard therapy for muscle-infiltrating tumors of the bladder remains radical cystectomy with or without radiation. Caution should be exercised about recommending newer regimens outside of clinical trials. However, combination chemotherapy programs can produce dramatic and durable remissions in a significant percentage of patients with advanced urothelial tract malignancies.
authors.affiliation: Department of Medicine, Memorial Sloan-Kettering Cancer Center.
authors.forename: C N
authors.initials: CN
authors.lastname: Sternberg
authors.forename: H I
authors.initials: HI
authors.lastname: Scher
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000532:radiotherapy; D003131:Combined Modality Therapy; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy
chemical_list: D000970:Antineoplastic Agents